CV Sciences (CVSI) Return on Capital Employed Growth (5y) (2016 - 2026)
CV Sciences (CVSI) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.94 Mn | 3.64 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,137.00 |
| Dec 31, 2025 | 8,820.00 |
| Sep 30, 2025 | 3,056.00 |
| Jun 30, 2025 | 324.00 |
| Mar 31, 2025 | -2,508.00 |
| Dec 31, 2024 | 15,251.00 |
| Sep 30, 2024 | 17,601.00 |
| Jun 30, 2024 | -9,082.00 |
| Mar 31, 2024 | -10,579.00 |
| Dec 31, 2023 | 6,697.00 |
| Sep 30, 2023 | 2,814.00 |
| Jun 30, 2023 | 1,817.00 |
| Mar 31, 2023 | 992.00 |
| Dec 31, 2022 | -103,571.00 |
| Sep 30, 2022 | -61,988.00 |
| Jun 30, 2022 | -36,187.00 |
| Mar 31, 2022 | -31,123.00 |
| Dec 31, 2021 | -22,058.00 |
| Sep 30, 2021 | -9,738.00 |
| Jun 30, 2021 | -8,994.00 |